跳转至内容
Merck
CN
  • Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.

Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.

Journal of medicinal chemistry (2010-02-11)
Valentina Onnis, Cenzo Congiu, Emmelie Björklund, Franziska Hempel, Emma Söderström, Christopher J Fowler
摘要

Fatty acid amide hydrolase (FAAH) is the key hydrolytic enzyme for the endogenous cannabinoid receptor ligand anandamide. The synthesis and evaluation for their FAAH inhibitory activities of a series of 18 paracetamol esters are described. Structure-activity relationship studies indicated that the ester (33) with a 2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)phenyl)acetic acid substituent was the most potent analogue in this series. The compound inhibited FAAH activity in a competitive manner with a K(i) value of 0.16 microM. The compound was also able to inhibit the FAAH activity in rat basophilic leukemia cells as assessed by measuring either the hydrolysis of anandamide, the FAAH-dependent cellular accumulation of anandamide, or the FAAH-dependent recycling of tritium to the cell membranes. The compound also inhibited the activity of monoacylglycerol lipase (MGL), the enzyme responsible for the hydrolysis of the endogenous cannabinoid receptor ligand 2-arachidonoylglycerol, with an IC(50) value of 1.9 microM. It is concluded that the compound may be a useful template for the design of potent novel inhibitors of FAAH.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
布洛芬, ≥98% (GC)
Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
( S )-(+)-布洛芬, ReagentPlus®, 99%
Supelco
布洛芬
Sigma-Aldrich
吲哚美辛, meets USP testing specifications
Sigma-Aldrich
布洛芬, meets USP testing specifications